Use of clinicopathological factors to predict prognosis of fertility-sparing treatment for endometrial endometrioid carcinoma and atypical hyperplasia

The incidence of endometrial endometrioid carcinoma (EEC) has been gradually increasing over the past decade. Fertility-sparing therapy with progestin is a treatment option for EEC or endometrial atypical hyperplasia (AH). The present study evaluated the role of numerous prognostic factors following...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xiaobo, Zhao, Xiaoya, Wang, Chen, Lu, Shanshan, Wang, Yiqin, He, Yijiao, Wang, Jianliu, Shen, Danhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9811621/
https://www.ncbi.nlm.nih.gov/pubmed/36644134
http://dx.doi.org/10.3892/ol.2022.13638

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9811621/
https://www.ncbi.nlm.nih.gov/pubmed/36644134
http://dx.doi.org/10.3892/ol.2022.13638

Ejemplares similares